278 related articles for article (PubMed ID: 20717951)
21. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC
Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
[TBL] [Abstract][Full Text] [Related]
22. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.
Chervinsky P; Philip G; Malice MP; Bardelas J; Nayak A; Marchal JL; van Adelsberg J; Bousquet J; Tozzi CA; Reiss TF
Ann Allergy Asthma Immunol; 2004 Mar; 92(3):367-73. PubMed ID: 15049402
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
24. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
Cingi C; Ozlugedik S
Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
[TBL] [Abstract][Full Text] [Related]
25. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
Patel P; Patel D
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
[TBL] [Abstract][Full Text] [Related]
26. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Lu S; Malice MP; Dass SB; Reiss TF
J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
[TBL] [Abstract][Full Text] [Related]
27. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
Mucha SM; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
[TBL] [Abstract][Full Text] [Related]
28. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence.
Adsule SM; Misra D
J Indian Med Assoc; 2010 Jun; 108(6):381-2. PubMed ID: 21121394
[TBL] [Abstract][Full Text] [Related]
29. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
Saengpanich S; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
31. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Nayak A; Langdon RB
Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
[TBL] [Abstract][Full Text] [Related]
32. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
Wilson AM; Orr LC; Coutie WJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
[TBL] [Abstract][Full Text] [Related]
34. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
[TBL] [Abstract][Full Text] [Related]
35. Montelukast in allergic rhinitis: a systematic review and meta-analysis.
Grainger J; Drake-Lee A
Clin Otolaryngol; 2006 Oct; 31(5):360-7. PubMed ID: 17014443
[TBL] [Abstract][Full Text] [Related]
36. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis.
Schäper C; Gustavus B; Koch B; Ewert R; Hanf G; Kunkel G; Noga O; Gläser S
J Investig Allergol Clin Immunol; 2009; 19(6):459-64. PubMed ID: 20128420
[TBL] [Abstract][Full Text] [Related]
37. The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence.
Santos CB; Hanks C; McCann J; Lehman EB; Pratt E; Craig TJ
Allergy Asthma Proc; 2008; 29(2):140-5. PubMed ID: 18430310
[TBL] [Abstract][Full Text] [Related]
38. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
39. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
40. [The role of leukotriene D4 antagonist in allergic rhinitis with steroid resistance].
Qu S; Li T; Chen Y; Lin Z; Ou Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun; 19(12):557-9. PubMed ID: 16176012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
